Please log in
to access more information

loading...

User name and Password not recognised

Home Page > News

December 6TH, 2018

Saint-Priest, France, December 6, 2018, 8:00 (Paris time) – Biom’up (the "Company"), a specialist in surgical hemostasis, announces the success of its private placement financing of €7.67 million through a capital increase by the issuance of new shares without preferential subscription rights for the benefit of a category of beneficiaries (the "Offering"). The Company sold 1,597,332 new shares at a price of €4.80 per share, representing a discount of approx. 2% to the closing share price on December 5, 2018 (€4.90 per share). The Offering represents 12.61% of the Company’s existing share capital.

» Biomup - CP Pricing PIPE Décembre 2018 VO


December 5TH, 2018

Saint-Priest, France, December 5, 2018, 6:00 p.m. (C.E.T.) – Biom’up (the "Company"), a specialist in surgical hemostasis, announces the launch of a capital increase by the issuance of new shares without preferential subscription rights for the benefit of a category of beneficiaries (the "Offer"). Biom’up wishes to raise a minimum of €7 million.

» Biomup CP Pricing PIPE Décembre 2018 VO


November 28TH, 2018

Saint-Priest (France), November 28, 2018, 8:00 am (Paris time) – Biom’up (the “Company”), a specialist in surgical hemostasis, announces today an update on its first months of commercialization of HEMOBLAST Bellows in the US and Europe and confirms a strong uptake among hospitals and surgeons.

» BIOMUP_MarketMetrics_28.11.2018.pdf


November 8TH, 2018

Biom’up announces completion of the 2018 scale-up of its manufacturing facility to meet commercial demand for HEMOBLASTTM Bellows

2018 scale-up of Biom’up’s manufacturing facility near Lyon (France) completed, allowing for a larger throughput and increased shipments of devices to the US and EU markets

Six key manufacturing processes upgraded, thoroughly reviewed and approved by the FDA and EMA; a strong validation of the Company capability to efficiently execute a comprehensive and demanding regulatory plan

Biom’up reaches a new important milestone in its growth strategy and continues to execute in line with commitments made at IPO

Saint-Priest (France), November 08, 2018, 8:00 am (Paris time) – Biom’up (the “Company”), a specialist in surgical hemostasis, announces today the completion of the 2018 scale-up of its manufacturing facility to meet commercial demand for HEMOBLASTTM Bellows, in the US and selected national markets in the EU. 

Download the full press release below: 

» 2018 0611 PR Biom'up US EU Launch EN.pdf


OCTOBER 16TH, 2018

Biom’up announces a first distribution agreement in Europe and the filing of a reimbursement dossier with Australian health authorities

The Company signed a first exclusive distribution agreement in Europe with Spain’s Palex Medical SA, a leading distributor of medical devices. A first shipment to Spain is expected at the end of 2018 with an official market launch scheduled in Q1 of 2019.


In Australia, the Company filed a reimbursement dossier for HEMOBLASTTM Bellows in the Prostheses list. Feedback from the Australian health regulators is expected in H1 2019.

» PR_Biomup_SpainAustralia_10162018.pdf


SEPTEMBER 13TH, 2018

H1 2018 RESULTS
ON TRACK WITH THE COMPANY’S BUSINESS PLAN 

▪ €41 million raised through a capital increase and an OBSA bond issue

▪ Successful implementation of commercial infrastructures in the United States

▪ Reinforced management team

Saint-Priest, France, September 13, 2018 – 8:00 CEST – Pursuant to the adoption of the interim consolidated financial statements for the period ended June 30, 2018 by the Board of Directors on September 12, 2018, Biom’up (the "Company"), specialist of surgical hemostasis, today announces its first-half results.

The statutory auditors have performed a limited review of the consolidated financial statements adopted by the Board of Directors on September 12, 2018.

Etienne Binant, Chief Executive Officer of Biom’up, commented: "Biom’up has made significant progress since its successful IPO in October 2017. The two financing deals completed at the start of the year, i.e. the capital increase through a public offering and the bond issue with stock warrants attached, have allowed the Company to raise €41 million since the IPO, thus ensuring we have the resources to match our ambitions over the medium-term. The first half results published today reflect our efforts of the last six months, focused on financing, increased production capacity and the successful implementation of our commercial infrastructure in the United States. The remainder of the year will be focused on launching the construction of the second manufacturing facility near Saint-Priest, the expansion of the hemostatic line with continuing studies required for HEMOBLASTTM Bellows and HemosnowTM and, of course, the commercial launch of our lead product in the United States". 

» Biomup_-_PR_RFS_2018_VO_4134-9267-7399_2_c79b7.pdf


SEPTEMBER 4TH, 2018

Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth

 

Saint-Priest (France), September 4, 2018, 8:00 a.m. (CET) – Biom’up (the "Company"), a specialist in surgical hemostasis, today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director. Dr. Byloos’ international experience in the healthcare and medical equipment sectors, combined with his knowledge of the US market will contribute additional support to Biom’up’s management team as the commercial roll-out of its lead product, HEMOBLASTTM Bellows, hits North America.

 

Download the full press release below: 

» Biom up CP ENG.pdf


JULY 25th, 2018

Biom’up present at the 8th Strategic Council of Health Industries hosted by France’s Prime Minister

 

-An illustration of Biom’up’s first achievements and growing position in international markets

-Significant growth of the number of U.S. hospitals undergoing a medical-economic evaluation of HEMOBLASTTM Bellows

-A strengthened sales force in the United States 

 

Download the full press release below: 

» Biomup_PR_EN.pdf


JULY 12th, 2018

Biom’up obtains CE Mark for its HEMOBLASTTM Bellows Laparoscopic Applicator

-An additional device designed to deliver the HEMOBLAST Bellows powder in minimally-invasive procedures

-Biom'up ready to address a new European market segment where traditional hemostatic products are generally difficult to use or unusable

-Yet another important milestone enabling Biom’up to address a new market of approximately 500,000 surgeries per year in Europe 

Download the full press release below: 

» Biomup_PR_applicator _12072018_a79f0.pdf


JULY 3TH, 2018

Biom’up announces first sales of HEMOBLAST™ Bellows in the United States and the nomination to its board of directors of an independent director and an observer to support the company’s growth

- The first batch of HEMOBLAST™ Bellows was shipped to the United States in June, offering a test run for the entire supply chain and customs for its flagship product 

- A first supply agreement was signed with the UCLA Medical Center, a leading hospital in the Los Angeles area 

- Master agreements are in the process of being negotiated with more than 75 hospitals throughout the United States 

- The first deliveries to hospitals were made on July 2 

- On July 2 the company filed a supplement to obtain FDA approval for HEMOBLAST™ Bellows for use in laparoscopic surgery 

- An independent director and a non-voting observer are appointed at the company’s board of directors to support its development in North America 

 

Download the full press release below: 

» Biomup_PR.pdf


MAY 2TH, 2018

Biom’up finalizes U.S. commercial organization to support U.S. launch of HEMOBLASTTM Bellows

 

- U.S. team of more than 100 specialist sales representatives & seasoned management in place

- On track with clinical, regulatory, financial, and commercial milestones

 

Download the full press release below: 

» Biomup_PR_US_orga .pdf


APRIL 24TH, 2018

Biom’up has trained 200 surgeons in the US and in Europe ahead of HEMOBLAST™Bellows launch

 

- 200 KOLs and surgeons trained across the U.S. and Europe to date 

- Objective is to continue training a maximum of surgeons before the official launch of HEMOBLAST Bellows in mid-2018 

 

Download the full press release below: 

» Biomup_PR_surgeon_training_EN.pdf


APRIL 16TH, 2018

Biom'up reports 2017 full-year results and provides corporate update

 

- 2017 results underscore focus on establishing a strong financial foundation as basis for commercial strategy going forward

- A total of c. €100 million raised through 2017 to date

- Marketing approval lead product HEMOBLASTTM Bellows obtained from the U.S.

FDA in December 2017, 7 months ahead of schedule

- 2018 focus on product launches, scale-up of manufacturing and hemostatic product portfolio expansion


Download the full press release below:  
 

» Biom'up reports 2017 EN .pdf


MARCH 27TH, 2018

Biom’up Appoints Thierry Darnis as Global Vice President, Manufacturing & Engineering



Thierry Darnis, 54, brings extensive experience in the management of major manufacturing sites for medical devices, acquired at top-tier global companies. At Medtronic and CR Bard he managed plants pursuing a successful twofold objective of increasing volumes, while optimizing costs. Before joining Biom’up, Thierry Darnis was deputy chief executive officer of Sofradim Production, a subsidiary of Medtronic plc (Dublin, Ireland/Minnesota, USA), in charge of the Trevoux plant (340 employees) that he managed for more than 12 years. He has a Ph.D. in Life and Health Sciences, specialized in Biomaterials, from the University of Bordeaux II. (...) 

 

Download the full press release below:  

» PR Biom'up thierry Darnis EN.pdf


MARCH 07TH 2018

NAMSA – Biom’up Achieves Record-Breaking Medical Device Development Timelines with NAMSA’s MRO® Approach

Interview of Etienne Binant, Biomu’up CEO and Rachid Zerouali, Sales director EMEA at Namsa

Watch the full video: http://NAMSA – Biom’up Achieves Record-Breaking Medical Device Development Timelines with NAMSA’s MRO® Approach Interview of Etienne Binant, Biomu’up CEO and Rachid Zerouali, Sales director EMEA at Namsa Watch the full video: https://www.youtube.com/watch?v=M4rbvoJ90_U


MARCH 6TH, 2018

Biom’up is proud to receive the Lyon Metropolis president (David Kimelfeld) in our headquarters in St-Priest.

 

 


FEBRUARY 20TH, 2018

Biom'up completes the first of its financing operations for a total amount of more than €40 million

 

“Biom’up wishes to thank all its investors those from France and those from further afield, those who have long supported us and those who have only recently come on board for making this fundraising transaction a success. The €16 million capital increase will enable us to accelerate the industrial development of Biom'up, and to prepare the expansion of our hemostatic range. As planned, these funds will be used to accelerate the ramp-up in our production in connection with the launch of HEMOBLAST™ Bellows and further clinical efforts on HEMOBLAST™ Bellows andHEMOSNOW™ ”. Etienne Binant, Biom’up’s Chief Executive Officer
 
Download the full press release bellow:  

» BiomUp_PR_EN Capital increase.pdf


FEBRUARY 15, 2018

Markets Insider - Biom’up Announces a Financing Targeting a Total of €43m

 

Regulatory News:

Biom’Up (the "Company”) (Paris:BUP), specialist in surgical hemostasis, announces today a financing operation consisting of:

(i) a capital increase by means of a public offering without preferential subscription rights for shareholders and with a priority subscription period, as of right only, for existing shareholders (the "Capital Increase”), of an initially planned amount of €18 million, which may be increased to a maximum of €20.7 million if the increase option is exercised in full and independently;

(ii) a proposed bond issue with stock warrants of an initial amount of €25 million which may be increased to €35 million with Athyrium Capital Management, L.P. ("Athyrium”), an investment fund management company, with which the Company has entered into exclusive negotiations. This proposed bond issue is not subject to Athyrium acquiring a stake in the Company within the framework of the Capital Increase. However, it is subject to the Capital Increase achieving at least €15m of its initial amount.

 

Read more: http://markets.businessinsider.com/news/stocks/biom-up-announces-a-financing-targeting-a-total-of-43m-1015730430


FEBRUARY 14, 2018

Euronext - Biom’up Announces a Financing Targeting a Total of €43m

 

Capital increase of an initial amount of €18m which may be increased to €20.7m by means of a public offering without preferential subscription rights and with a priority subscription period of three trading days as of right only

Proposed bond issue with stock warrants of an initial amount of €25m which may be increased to €35m for the benefit of investment funds managed by Athyrium Capital Management, a major US investor in the healthcare sector, which also agrees to take part in the capital increase

The proposed bond issue, which is subject to the Capital Increase achieving at least €15m of its initial amount, will enable the company to refinance the Kreos Capital loan of €8.2m (...) 

 

Read more: https://www.euronext.com/en/cpr/biom’-announces-financing-targeting-total-€43m

 

 


JANUARY 25, 2018

CONGRESS : SFCE 2018 

25-27 january 2018 

 

Come visit us : stand A04. 

Attend our symposium regarding HEMOBLAST™Bellows: The first active hemostatic powder. 

Friday, January 26 2018 at 1:15 pm to 1:35 pm at Espace Technologique, Palais Brongniart, Paris 

 


DECEMBER 18TH, 2017

Biom’up receives FDA marketing approval  for HEMOBLASTTM Bellows, its flagship product 


 
-Approval granted several months ahead of the initial schedule

-Launch of HEMOBLAST™ Bellows in the United States expected over the summer in 2018 

 

Read more: 

» PR 18.12.17.PDF


DECEMBER 13TH, 2017

Biom’up to be included in the Euronext’s CAC® Small, CAC® Mid & Small and CAC® All-Tradable indexes 

 

Saint-Priest, France, December 13, 2017 – Biom’Up, specialist in surgical hemostasis, announces today that, as of Monday December 18, 2017, it will be included in three new CAC-family indexes: CAC® Small, CAC® Mid & Small and CAC® All-Tradable. 
The inclusion of Biom’Up shares in these indexes follows an analysis of the share by Euronext based on its free float market cap, and illustrates investor interest in Biom’Up, which recently reached a crucial milestone in its FDA approval process with the positive outcome of the inspection of the production facilities on Biom’up’s Saint Priest site by of the American Food & Drug Administration (FDA). 
The Euronext Paris Indexes’ Scientific Committee took this decision during its quarterly review of these indexes on December 7, 2017. 

Read more: 

» PR 13.12.17.PDF


DECEMBER 07tH, 2017

Biom’up appoints Cécile Ferracci as Global Vice President Marketing 

Etienne Binant, Chief Executive Officer of Biom’Up, says: “I am delighted to welcome Cécile Ferracci to Biom’up as our Global Vice-President, Marketing. Her solid and diverse experience within global medical technology companies represents a crucial asset for Biom’up’s success at a key time in its history. Her inclusion in the Company’s Executive Committee will enable her to have a maximum impact on HEMOBLASTTM Bellows’ launch strategy in Europe and the United States, in close cooperation with our regional sales and marketing managers.”

Read more: 

» PR 06.12.17.pdf


NOVEMBER 09, 2017

Biom’up confirms the success of its IPO

 

Reinforcement of shareholders' equity of €60 million through the initial public offering of witch: - around €42.5 million within the frame of the offer - €17.3 million in bonds capitalization  
Implementation of a liquidity contract with CM-CIC Market Solutions 

 

Read more: 

» PR 09.11.17.pdf


OCTOBER 27th, 2017

Biom’up provides regulatory update regarding HEMOBLAST™ Bellows 

 

Saint-Priest, France, October 27, 2017 – Biom’Up, specialist of surgical hemostasis, today provides a regulatory update regarding the United States Food and Drug Administration’s (FDA) review of the company’s Premarket Approval (PMA) application for its HEMOBLASTTM Bellows. 
 
The FDA conducted a PMA pre-approval inspection at the Biom’up Saint Priest, France, manufacturing facility. The four-day Premarket Approval inspection focused on the firm’s HEMOBLASTTM Bellows product line and did not result in any FDA-483, Inspectional Observations.  
This inspection was part of the medical device approval process to market HEMOBLASTTM Bellows within the United States of America. Following the inspection, the FDA will provide the company with an inspection report and continue its review of the PMA.  

Read more: 

» PR 27.10.17.pdf


OCTOBER 11th, 2017

Biom’up announces the success of its IPO,  raising close to €38.1 million on Euronext Paris 

 

-First initial public offering in the healthcare sector on the Euronext regulated market in Paris in the last 6 months 
 
-Strong institutional demand in France as well as abroad, especially in the United States and the United Kingdom: o balanced representation between general investors and healthcare specialists o Top 10 investors represented nearly 80% of institutional demand, a strong confidence in the company's fundamentals 
 
- Significant over subscription enabling an upsized transaction under favourable conditions:

€38.1 million raisedfollowing the full exercise of the Extension Clause o Biom’Up could raise up to €43.9 million in the event the Overallotment Option is fully exercised 

-Offering Price set at €10.5 per share at the midpoint of the IPO range 
 
-Market capitalization of approximately €113 million   

-Trading will begin on Friday October 13, 2017

Read more: 

» PR 11.10.17.PDF


SEPTEMBER 26TH, 2017

Biom’Up launches its IPO on the Euronext regulated market in Paris

Saint-Priest, France, September 26, 2017 – Biom’Up, specialist of surgical hemostasis, today announces the launch of its IPO on the Euronext regulated market in Paris.

The Autorité des Marchés Financiers (AMF, the French financial markets authority) granted visa number 17- 508 dated September 25, 2017 for the prospectus relating to the IPO of Biom’Up shares.

» Biom'up PR - 26/09/2017


September 12th, 2017

Biom’Up announces the filing of its Document de base within the framework of its planned IPO on the Euronext Paris regulated market

Saint-Priest, France, September 12, 2017 – Biom’Up, specialist of surgical hemostasis, announces that it filed its Document de base (source document) with the Autorité des Marchés Financiers (AMF, the French stock market authorities) on September 11, 2017 under the reference number I.17-064, within the framework of its planned IPO on the Euronext Paris regulated market.
The filing of the Document de base represents the first step in Biom’Up’s planned IPO on the Euronext Paris regulated market, contingent on market conditions and regulatory prerequisites, and notably the granting of a visa by the AMF for the prospectus that has to be drawn up relative to this operation.

» Biomup IPO PR DDB


December 20th, 2016

Biom'up receives CE Mark Approval for HEMOBLAST™ Bellows, the first active hemostatic powder for management of mild to moderate intra-operative bleedings

Lyon (France), December 7th, 2016
Biom’up announces today that it has received CE Marking for HEMOBLAST™ Bellows active hemostatic powder and delivery system. HEMOBLAST™ Bellows is indicated in open surgical procedures as an adjunct to hemostasis when control of bleeding by conventional techniques is ineffective or impractical. HEMOBLAST™ Bellows is indicated in the following surgical specialties: cardiac, vascular, abdominal, urology, gynecology, orthopedic, spine, ear nose and throat (ENT), and head and neck.

[...]

» biom'up press release


July 15th, 2016

Biom’up, Saint Priest, Lyon, July 15th 2016.  
Today biom’up announced the enrollment of the first patient in their prospective, randomized, controlled, multicenter, pivotal, clinical investigation evaluating the safety and efficacy of HEMOBLASTTM Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries.

 
HEMOBLASTTM Bellows is an investigational device, not currently for sale in the US that is intended for use in surgical procedures as an adjunct to hemostasis when control of bleeding by conventional procedures is ineffective or impractical.   


Since its formation in 2005, biom'up has been developing medical devices based on patent protected biopolymers. Using this experience, biom'up has created innovative and clinically proven products that cover many different surgical specialties - orthopedics, spinal, cardiac, general, and maxillo-facial and dental. biom'up is committed to the design and development of novel high-performing solutions for a better patient outcome.  

» HEMOBLAST Bellows enrollment of the first patient PR.PDF


MAY 12, 2016

Today Biom'Up announced it has received FDA clearance for the HEMOBLASTTM Bellows IDE pivotal clinical trial design.

The prospective, randomized, controlled, multi-center clinical investigation evaluates the safety and efficacy of HEMOBLASTTM Bellows, the company’s novel hemostat, in cardiothoracic, abdominal, and orthopedic lower extremity surgeries.

The study meets the FDA requirement for reliability by establishing the eligibility of the target bleeding site and achievement of hemostasis based on the SPOT GRADETM, a validated Surface Bleeding Severity Scale (SBSS), that is a proprietary creation of Biom’Up. (...)

» Biom'up press release


SEPTEMBER 9TH, 2015

Biom’Up secures EUR 31,3 million in Series C financing from Bpifrance Large Venture, Gimv and Lundbeckfond Ventures.

St-Priest, 9 September 2015, 7:30 AM CET – Biom’Up today announced that the company has secured EUR 31,3 million in a Series C financing round from an investment syndicate consisting of Gimv, Bpifrance Large Venture and Lundbeckfond Ventures, alongside its existing shareholders (InnoBio, Sham Innovation Santé, ACG Management, Sofimac, Mérieux Développement, OTC AM, Euroainvest and l’Améliane) and the company’s management team. This third institutional financing round represents a milestone for the international growth and scaling of the business... 

Find the full press release below,

» Biom'up press release


APRIL 2015

Biom'up continues its ascent with the promising research and development project progression: HEMOBLAST™ Bellows.

Lyon (France), April 1, 2015
Biom’Up announced today that it has received FDA IDE approval to begin studies in human patients on the HEMOBLAST™ Bellows hemostatic powder and delivery system. The initial phase of study will focus on Biom’Up’s system for evaluating bleeding severity as well as product safety followed by a multi-center, multi-national pivotal trial.

Find the full press release below,

» Biom'up press release


MARCH 20th,2015

Biom'up continues its ascent with the promising research and development project progression: COLOMATRIX.

Lyon (France), March 20, 2015
Biom’Up announced today that it has received public funding from the French State, the Rhone-Alpes Region, the Grand Lyon Metropole, the General Council of Isere and the FEDER European funds. These funds will be used to develop an innovative collagen-based medical device for the prevention of one of the major causes of morbidity and mortality in digestive surgery. The device will combine high tech polymers and textiles for unique biological and mechanical properties. This project is approved by Lyonbiopole and Techtera – two leading competitiveness clusters [...]

Find the full press release below,

» Biom'up press release


22 November 2013

Biom’Up: a first clinical study demonstrates the potential of COVATM+ CARD membrane in pediatric cardiology & heart surgery


• This collagen membrane forms a resorbable barrier to provide the guided healing of organs and tissues along distinct anatomical planes
• The clinical study that included 36 patients demonstrates the good tolerance of the membrane and its benefit for the patient: no severe adherence was observed, contrary to the usual practice
• These results have been reviewed and published in “Archives of Cardiovascular Diseases”, the official review of the French Society of Cardiology


Lyon, France, December 02, 2013 - Biom'Up, a specialist manufacturer of absorbable medical implants, today announces the results of a first clinical study in pediatric cardiac surgery.

» BiomUp press release 22 11 2013 EN.pdf


BIOM’UP RAISES €3 MILLION FROM THE €10 MILLION CREDIT LINE GRANTED IN MARCH 2018 BY ATHYRIUM

Saint-Priest, France, December 31, 2018, 6:00 PM (CET) – Biom’up (the “Company”), a specialist in surgical hemostasis, today announces the success of the partial issue of the second tranche of its bond financing for €3 million out of the €10 million available. 

» Download the press release


June 13th, 2013

Biom'Up launches the COVAMESH™ abdominal wall reinforcement implant

Featuring Cova(TM) technology, the double-sided wall reinforcement implant represents real practical progress for
laparoscopic procedures, significantly reducing the risk of adhesions

Lyon, France, June 14, 2013 – Biom'Up, a specialist manufacturer of absorbable medical implants, today announces the launch of its new wall reinforcement implant, Covamesh. Made from Biom'Up's anti-adhesion collagen membrane, Cova, and a polyester textile layer with special markings for ease of placement during surgery, Covamesh is designed to fulfil surgeons' needs in abdominal surgery, particularly in laparoscopic procedures.

» Biom'Up Press


October 25th, 2012

Biom’Up raises EUR 6.8 million

 

These funds will be used to accelerate the company’s commercial development and finance clinical studies into two future innovative ranges of medical implants.

Lyon, October 25, 2012 - Biom’Up, a young company specialised in the manufacture of re-absorbable medical devices, announces today that it has raised EUR 6.8 million in new funds from existing shareholders and acquired three new investors: the InnoBio fund, managed by CDC Entreprises under the ‘FSI France Investissement’ program, Viveris Management and OTC Asset Management.

» BiomUp press release 25 10 2012 EN.pdf


SEPTEMBER 10TH, 2018

CONGRESS- PSOGI 

 

September 10th, 2018

 

Biom'up will have a Symposium at PSOGI Congress in Paris, Maison de la Chimie (11:45 to 12:15 in the Plenary Room) 

Speakers: Dr.D Goere, Paris France / C. Cochereau, PhD, VP Clinical and Regulatory affairs, Biom'up / A. De Gasperis, PhD, R&D Project Manager, Biom'up 

Don't miss it! 

Read more:  https://www.psogi2018.com/


MAY 30th, 2018

CONGRESS – EAES

 

from May 30th to June 1st  2018 

London, UK 

 

Biom’up will be at the 26th International EAES Congress  "European association for Endoscopic Surgery"

 

Read more https://eaes.eu/eaes2018/


JUNE 7th, 2018

CONGRESS - SFCR

 

from 7th to 9th of june 2018

Nantes, La cité des Congrés

 

Biom’up will be at the " Annuel de la Société Française de Chirurgie rachidienne" 

 

Read more http://www.sfcr.fr/congres-sfcr/programme


JUNE 13th, 2018

CONGRESS – SFCTCV 

 

from 13th to 15th  june 2018

Lille, France 

 

Biom’up will be at the 71ème édition du congrès de la SFCTCV ( Société Française de la chirurgie thoracique et cardio-vasculaire) 

 

Read more :http://https://www.sfctcv.org/agenda/congres-sfctcv-2018/


JUNE 29th, 2018

CONGRESS – SPINE TUMOR DAYS 

 

from June 29th to 30th 2018

Dresden, Allemagne 

 

Biom’up will be at the 5th International Spine Tumor Days

 

Read more http://www.spine-tumor.com/


SEPTEMBER 19TH, 2018

CONGRESS – EUROSPINE 

 

from September 19th to 21st  2018

Barcelona, Spain 

 

Biom'up will be at the European Spine Society Annual Meeting 2018 

 

Read more http://eurospine-2018.com/?gclid=Cj0KCQjwy9LVBRDOARIsAGqoVnu2aBXufEaHt66RGXgfe-XfkCbt9pJpf1EnnBp41Fwd9qfp7KAon50aAmAcEALw_wcB


SEPTEMBER 19TH, 2018

CONGRESS – AFC

 

from September 19th to 21st 2018

Paris, France

 

Biom’up will be at the French Association of Surgery Congress

 

Read more: https://en.convention.parisinfo.com/paris-show-exhibition/140649/AFC-Congr%C3%A8s-de-l%27Association-Fran%C3%A7aise-de-Chirurgie


OCTOBER 16th, 2018

CONGRESS – EURO-PHARMAT

 

from 16th to18th October  2018

Nancy, France

 

Biom’up will be at the  "28èmes journées Euro-Pharmat"

 

Read more http://www.euro-pharmat.com/prochaine-edition-nancy


OCTOBER 18TH, 2018

CONGRESS – EACTS

 

from October 18th to 20th 2018

Milan, Italy

 

Biom’up will be at the European Association For Cardio-Thoracic Surgery Annual meeting 

 

Read more:  http://www.eacts.org/educational-events/eacts-annual-meeting/


OCTOBER 21ST, 2018

CONGRESS – AMERICAN COLLEGE OF SURGEONS 

 

from 21st to 25th October 2018

Boston, USA 

 

Biom'up will be at the "Clinical congress" of the American College of Surgeons 

 

Read more https://www.facs.org/clincon2018


MARCH 24th 2018

CONGRESS – Patient Blood Management

 

March 24th 2018

Goethe University, Frankfurt, Germany

 

Biom'up will be at the "Patient Blood Management" congress 

 

Read more : https://www.patientbloodmanagement.de/wp-content/uploads/2018/03/2018_01_30-Flyer-Global-PBM-Symposium-2018-_ENG_LQ.pdf


MAY 15th, 2018

CONGRESS – AIFIBODE

 

from 15th  to 17th  May 2018

Paris, Palais des Congrès  

 

Biom’up will be at the "35ème JNEP de l’UNAIBODE" (Union Nationale des Associations d'Infermiers de Bloc Opératoire Diplomés d'Etat)

 

Read more: https://jnep2018.unaibode.fr/programme-jnep-paris-2018 


APRIL 17TH, 2018

CONGRESS – German Society of Surgery 

 

from 17th  to 20th  April 2018

Berlin, Germany

 

Biom’up will be at the German Society of Surgery Annual Congress 

Visit our booth ! 

 

Read more: http://chirurgie2018.de/index.php​


MAY 16TH, 2018

CONGRESS – SGC 

 

from 16th  to 18th  May 2018

Basel, Switzerland

 

Biom’up will be at the "Schweizerischen gesellschaftfürchirurgie" annual congress 

We look forward to seeing you ! 

 

Read more: http://sgc-ssc.ch/index.php?id=235


MARCH 1st, 2018

CONGRESS:

March 1st, 2018  

 

Biom'up will be at the 8th NEUROspine Meeting

Bern, Switzerland 

Visit our Booth 5B


FEBRUARY 17, 2018

CONGRESS:

 From February 17th to 20th, 2018  

 

Biom'up will be at the 47th Annual Congress Meeting of the DGTHG (German Society of Thoracic and Cardiac Surgery), 

Leipzig, Germany

Visit our Booth C.33


JANUARY 27, 2018

CONGRESS:

 Saturday 27, 2018 

 

Biom'up will be at the Gründung der "Gesellschaft für Wirbelsäulenchirurgie“ Congress this Saturday 27, 2018 

Visit our Booth #1 

http://www.spine.at/ 


From 10th to 12th October 2017 - EUROPHARMAT

We are Happy to annouce you that we will participate to Europharmat congress from 10th to 12th October in Saint Malo. 

 

Booth #92 

 

EUROPHARMAT / Palais des Congrès le Grand Large / Saint Malo


FROM 6 TO 8 JULY 2017 - ILLS

Come and see us at the ILLS congress from 6th to 8th of July in Paris - France! Booth #1

 

You can find the program  here 

 

ILLS / Maison de la Chimie / Paris / France 


From 7th to 9th June

We will be at the SFCTCV (French society of Thoracic and Cardio Vascular Surgery) congress from 7th to 9th June in Marseille

 

Booth #3

 

Consult the program 

 

SFCTCV / Parc Chanot / Marseille


From 19th to 21st January 2017 - SFCE Meeting

To start this New Year, we would be happy to meet you at the SFCE Meeting 2017 ! 

 

You can dowload the programm by clicking this link .

 

SFCE Meeting / Cité des Sciences et de l'Industrie / Paris


JUNE 11-13 2015 / GynMonaco

We are attending at the gynecological congress in Monaco.

Monaco- Fairmont Hotel

www.gyn-monaco.com


JUNE 12 2015 / Mesh congress

We are attending at the Mesh congress in Paris.

Paris- Maison de la Chimie

www.club-hernie-mesh.com


JUNE 12-13 2015 / Days of surgery in Paul Brousse center

Please come and find us at the Days of surgery in Paul Brousse center.

Paris- CAP15 Quai Grenelle


JUNE 25-27 2015 / Novamedica congress

Please come and find us at the Novamedica congress in Montpellier.

Montpellier- Corum

www.novamedica.org

 


MAY 22-23 2015 / SFCO

We are attending at the French Society of Surgical oncology in Bordeaux.

Bordeaux- Centre des Congrès Cité Mondiale

www.sfco.fr


APRIL 9-10 2015 / Digestive surgery days in Bordeaux

We are attending at the Bordeaux digestive surgery days.

Bordeaux- Hôtel Mercure Château Chartons 


APRIL 25-29 2015 / EHS Milan

Please come and find us at the EHS congress (1st World Conference on Abdominal Wall Hernia Surgery) in Milan.

Milan- MiCo congress center

www.hernia2015-milan.com


March 12-13 2015 / Choix des armes congress

Please come and find us at the Choix des armes congress in Marseilles

Marseilles- Cercle mixte de garnison

www.lechoixdesarmes.org


March 19-20 2015 / Club coelio congress

Please come and find us at the Club coelio congress in Paris.

Paris-Grande crypte

www.club-coelio.net


March 26-27 2015 / AFCA

We are attending at the AFCA congress in Lyon.

Lyon - Novotel Bron hotel


March 26-26 2015 / ESVCS

Please come and find us at the international congress of the European society for cardiovascular and endovascular surgery in Istanbul.

Istanbul- Hilton Istanbul Bomonti congress and Convention center

www.escvs2015.org


October 14-16, 2014 / Europharmat

Please come and find us at the Europharmat congress in Tours.

Tours- Centre des congrès Vinci

http://www.euro-pharmat.com/


November 6-7, 2014 / APECCO

We are attending at the APECCO congress in Tours.

Tours- Centre André Malraux Joué-les-Tours

www.apecco.com


November 7-8, 2014 / Digestive surgery congress in Nice

We are attending at the digestive surgery congress in Nice.

Nice- Grand hôtel Aston


November 26-28, 2014 / SFCD

We are attending at the SFCD congress in Disney.

Paris- Hôtel New-York Disney land

http://www.sfcd-achbt.fr/


September 18-20, 2014 / SFSCMFCO

We are attending at the SFSCMFCO in Lyon.

Lyon- Cité internationnale

http://sfscmfco2014


October 1-3, 2014 / AFC

We are attending at the AFC congress in Paris - Stand n°13.

Paris- Palais des congrès Porte Maillot

http://www.lepublicsystemepco.com/


September 17-14, 2014 / AECG-SCGP

Please come and find us in the AECG-SCGP congress in Paris.

Communication COVA™ + : - Dr P. Panel

                                                    - Dr A. Le Tohic

Paris- Stade Roland Garros

http://www.congres-aecg.fr/aecg-2013/


June 11-14, 2014 / SFCTCV

We are attending at the SFCTCV congress

Tours- International congress center Vinci

http://www.congres-sfctcv.fr/


June 13, 2014 / Mesh

Please come and find us in the Mesh congress

COVAMESH™ communication : Dr Jean-Pierre COSSA

Paris- Maison de la chimie


June 13-14, 2014 / Paul Brousse days

We are attending at the Hepatobilaire center Paul Brousse surgery days

Paris- CAP 15 Quai Grenelle


June 19-20, 2014 / Medico-surgical days in Toulouse

Please come and find us in the Medico-surgical days in Toulouse

Toulouse- Mercure Atria hostel

http://www.medico-chir-digestif.com/


28-29 March 2014 / Club Coelio congress

We are attending at the Club Coelio congress

COVAMESH™ communication :  Dr Eric Olagne friday 28/03 at 12h35

Lyon- Ecole Normale Supérieure

http://www.chirurgie-viscerale.org/rc/org/chirurgie-viscerale/


29 March 2014 / AIBOMP

Please come and find us in the AIBOMP congress

Toulouse- Blue Radisson hostel Blagnac


April 03-04, 2014 / Journée de chirurgie digestive de Bordeaux

Please come and find us in the day of digestive surgery in Bordeaux

Bordeaux- Mercure Château Chartrons

http://chirurgiedigestive.apoles-sante.com/


10 April 2014 / Videosurgery gynecological congress in Deauville

We are attending at the Videosurgery gynecological congress in Deauville

Deauville- Domaine de l'Amirauté Touques


May 15-16, 2014 / Beaujon days

Please come and find us in the Beaujon surgery Days

Clichy- Beaujon Hospital


May 22-23, 2014 / CNU St Malo

We are attending at the CNU congress in St Malo

Saint Malo- Hôtel du nouveau monde


May 22-24, 2014 / SOFFCO

Please come and find us in the SOFFCO congress

Versailles- Palais des congrès


24-25 January 2014 / 24H Coelio

Please come and find us in the 24H Coelio congress

Bordeaux- Centre des congrès Cité mondiale

http://www.lasfce.com/?24H-COELIO-24-25-JANVIER-2014


22-23 November 2013 / Congress of digestive surgery in Nice

Please come and find us in the congress of digestive surgery.

Nice- Hôtel Méridien


27-29 November 2013 / SFCD

We are attending at the SFCD.

Paris- Disney hôtel New-York

www.lepublicsystemepco.com


29-30 November 2013 / DSD

Please come and find us at the DSD congress, congenital anomalies of genito-sexual development.

Lyon- Centre des congrès


7-8 November 2013 / 9th Daniel Dargent days of gynecological surgery

Please come and find us at the 9th Daniel Dargent days of gynecological surgery.

Lyon- Centre des congrès, cité internationale


14-15 November 2013 / APECCO

We are attending at the APECCO congress.

Angers- Centre des congrès

www.asconnect-evenement.fr


11-13 September, 2013 / SFCP

Please come and find us at the SFCP congress

St Malo- Palais du Grand large

www.chirpediatric.fr


18-20 September, 2013 / AECG

We are attending at the AECG congress

Paris- Stade Roland Garros

www.congres-aecg.fr


19-20 September, 2013 / FCPC

Please come and find us at the FCPC congress

Nantes- CCI salon des Salorges


26-28 September, 2013 / ESPES

We are attending at the ESPES congress (3rd Annual Meeting of thE European Society of Paediatric Endoscopic Surgeons)

Marseille- Hôpital la Timone enfants

www.espes.eu


2-4 October, 2013 / AFC

Please come and find us at the AFC congress

Paris- Palais des congrès

www.chirurgie-viscerale.org


8-10 October / Europharmat

We are attending at the Europharmat congress

Montpellier- Centre des congrès le Corum

/www.euro-pharmat.com


29 June / 7th day of medico-surgical Limousin

Please come and find us at the day of medico-surgical Limousin

Limoges- ENSIL Parc d'Ester Technopole


4 April 2013 / Day Gynecological Surgery

Please come and find us at the day of Gynecological Surgery

Angers- CHU Angers


5-6 April, 2013 / Lyon coelio international congress

Please come and find us at theLyon coelio international congress,

Stand n° 7

Lyon-Espace tête d'or

http://www.coelio-surgery.com/


19 April 2013 / 21st day of surgery visceral region EST

We are attending 21st day of surgery visceral region EST.

Vittel- Palais des congrès


25-26 April 2013 / 16th day of digestive surgery in Bordeaux

We are attending 16th day of digestive surgery in Bordeaux

Bordeaux- Hôtel Mercure Château Charton


25-26 April 2013 / Days of Beaujon surgery

Please come and find us at the days of Beaujon surgery.

Clichy-Hôtpital Beaujon


29-31 May 2013 / Unaibode

Please come and find us at the Unaibode congress,

Deauville- Centre international de Deauville

http://www.unaibode.fr


30 May-01 June / Xème congress of SCGP

We are attending at the Xème congress of SCGP

Bordeaux- Hôtel Pullman Aquitania


6-8 June 2013 / SOFFCO congress

Please come and find us at the SOFFCO congress.

Stand n°30

Angers- Centre des congrès

http://www.soffco2013.com/


7 June 2013 / JNCDE

Please come and find us at the Nantaise days of Digestive and Endocrine surgery

Nantes-Centre Salorges

http://www.imad-nantes.org/manifestations-et-congres/journee-nantaise-de-chirurgie-digestive-et-endocrinienne.html


7-8 June / Days of Hepato-Biliaire center Paul Brousse

Please come and find us at the days of Hepato-Biliaire center Paul Brousse

Paris-Cap 15


12-15 June 2013 / SFCTCV

We are attending at the SFCTCV congress.

Marseille- Parc Chanot palais des congrès

http://www.sfctcv.net


14 June 2013 / IXème Symposium on parietal prothesis MESH

We are attending IXème Symposium on parietal prothesis MESH.

Paris-Maison de la Chimie

http://club-hernie-mesh.com


15-16 March, 2013 / 13th congress of the club coelio

We are attending 13th congress of  the club coelio.

Bruxelles-THON hôtel Bristol Stephanie


17-18 January 2013 / HEGP

We are attending at the lesson of European hand surgery.

Paris- Hôpital Georges Pompidou


24-26 January, 2013 / SFCE

Please come and find us at the SFCE

Stand n°04

Paris-Palais des congrès porte Maillot

http://www.e-laparoscopy.com
 


September 19-21, 2012 / AECG congress

Please come and find us at the days of gynecological surgery

Paris- Stade Rolland Garros

www.congres-aecg.fr


October 3-5, 2012 / AFC

We are attending 114th congress of digestive and general surgery.

Paris-Palais des congrès

www.congres-afc.fr


October 9-11, 2012 / EUROPHARMAT

Please come and find us at the EUROPHARMAT congress, we are located on stand n°96

Lille- Grand Palais

www.euro-pharmat.com


October 25 and 26, 2012 / APECO

Please come and find us at the 14th study an improvement days in videosurgery.

Nantes- Centre des congrès de la Fleuriaye (Carquefou)

www.apeco2012-nantes.com


November 8-10, 2012 / 9th congress of SCGP

Please come and find us at the 9th SCGP meeting.

Lyon- Cité internationale

www.scgp.asso.fr


November 16-17, 2012 / 10th congress of digestive surgery at Nice

Please come and find us at the 10th congress of digestive surgery,

Nice-Hôtel Meridien


November 28-30, 2012 / SFCD

Please come and find us at the 8th french congress of Digestive and hepatobiliary surgery.

Paris- Centre des congrès Hotel New-York

www.sfcd-achbt.fr


July 1-5, 2012 / 10th World Congress of the International Hepato-Pancreato-Biliary Association

Please come and find us at the 10th IHPBA congress, we are located on stand n°28

Paris- Palais des Congrès

http://www.ihpba2012.com


April 4 and 5, 2012 / "DIU de Chirurgie de l'Obésité"

We are attending 2nd Seminary of "DIU de Chirurgie de l'Obésité"

Tours (France) - CHRU Trousseau

 


March 16 and 17, 2012 / Congrès International Lyon Coelio-chirurgie

Please come and find us at the Congrès International Lyon Coelio-chirurgie

Lyon Villeurbanne - Espace Tête d'Or

http://www.coelio-surgery.com


March 16 and 17, 2012 / 12 Congress of Club Coelio

Please come and find us at the Club Coelio congress
Caen - Hopital Privé Saint-Martin
 


19-20-21 January 2012 / SFCE

Please come and find us at the 19th International Symposium in Laparoscopic Surgery, we are located on stand 04
Paris- Palais des Congrès Hall Bordeaux

http://www.lasfce.com


7-11 November 2011/ SOFCOT

Please come and find us at the 86th SOFCOT meeting, we are located on stand F02
Paris- Palais des Congrès
http://www.sofcot.fr/
 


22-26 November 2011/ ADF

We are attending the ADF 2011where the theme is ‘Patient wellbeing’
Paris - Palais des Congrès
http://www.adf.asso.fr/cfm/site/afficher_rubrique.cfm?rubrique=17
 


30 November - 2 December 2011/ SFCD

We are attending 7th French Congress of Digestive and Hepatobiliary Surgery
Paris- Centre de Congrès Disneyland® Paris n°9
http://www.sfcd-achbt.fr/events.php?IDManif=628&IDModule=71&IDRub=128
 


MAY 28-30 2015 / SOFFCO

Please come and find us at the SOFFCO congress in Lyon.

Lyon- Cité Internationale

Web site